Select Page

Cardiovascular

Home » Cardiovascular

Clinical Trial Characteristics of Cardiovascular Disease

Cardiovascular disease is the leading cause of death globally. According to “China Cardiovascular Disease Report 2018”, the current prevalence of cardiovascular disease in China is 290 million patients. Unhealthy diet, smoking, drinking, lack of exercise and other unhealthy habits have led to a sustained increase in the incidence of cardiovascular disease in China. It is estimated that about 3.5 million people in China die of cardiovascular diseases every year, accounting for 41% of the total causes of death, ranking the first among all diseases. From an epidemiological point of view, cardiovascular drugs are still an important area focused on public health. Global cardiovascular drug research and development is facing great challenges, however the market and R&D prospects remain very promising. In the clinical study/trials of cardiovascular diseases, some trials have screened subjects intensively; while some have cleaning period and run-in period, leading to high screening failure rate.

 

Advantages of Tigermed

Patient-focused clinical trial staff, extensive domestic and international clinical trial experience and good cooperation with experts in the cardiovascular field are highlighted by clients for selecting Tigermed as their partner of choice. Besides these criteria, the wide range of hospitals and patient centers to cooperate with are what sets Tigermed apart from other CROs. Also we have a specific focus on indications of hypertension and hyperlipidemia.

 

Project Experience

The cardiovascular team is managed by 6 medical directors and >10 project managers with average working experience of 7 years. To share some insight into our current trials, 4 are in phase II, 12 in phase III, and 5 in large-scale phase IV/NIS projects.

Our clinical trial experience includes but is not limited to the following cardiovascular diseases:

  • Essential hypertension
  • Hyperlipidemia
  • Chronic heart failure
  • Arrhythmias (ventricular premature beats, atrial fibrillation, etc.)
  • Coronary heart disease (acute coronary syndrome, stable angina, etc.)